Evidence map›Paper›PMID 19524162›Full record

ArticleAmerican journal of preventive medicine2009

Project HeartBeat! Concept, development, and design.

Darwin R Labarthe, Shifan Dai, R Sue Day, Janet E Fulton, Jo Anne Grunbaum, Syed M Shah, Eugene Wen

Abstract read
In one paragraph

Article in American journal of preventive medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Findings from Project HeartBeat! Their importance for CVD prevention.American journal of preventive medicine · 2009
    Article
  7. Analytic methods in Project HeartBeat!American journal of preventive medicine · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Darwin R LabartheDivision for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Atlanta, GA 30341-3717, USA. dlabarthe@cdc.gov
Shifan Dai
R Sue Day
Janet E Fulton
Jo Anne Grunbaum
Syed M Shah
Eugene Wen

Funding

PRECURSORS OF CVD RISK FACTORS--PROJECT HEARTBEATR03HL057101 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LABARTHE, DARWIN R. · 1996 to 1997
–
EPIDEMIOLOGY OF CARDIAC DEVELOPMENT IN YOUTHR03HL059223 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LABARTHE, DARWIN R. · 1997 to 1998
–
PEDIATRIC EPIDEMIOLOGY OF CVD RISK FACTORSU01HL041166 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LABARTHE, DARWIN R. · 1990 to 1995
–
NHLBI NIH HHS 1R03 HL57101NHLBI NIH HHS 1 R03 HL59223NHLBI NIH HHS U01 HL041166NHLBI NIH HHS U01 HL41166PHS HHS 00IPA24501PHS HHS P0# 0009966385PHS HHS U48/CCU609653
6 · The paper itself

Abstract

Major cardiovascular disease (CVD) risk factors begin development in childhood and adolescence. Project HeartBeat! studied early development of these risk factors as growth processes. Growth, body composition, sexual maturation, major CVD risk factors, and cardiac structure and function were monitored every 4 months for up to 4 years among 678 children and adolescents (49.1% girls; 20.1% blacks) aged 8, 11, or 14 years at study entry. All resided in The Woodlands or Conroe TX. Interviews were conducted at entry and annually on diet, physical activity, and health history of participants and their families. Data were collected from 1991 to 1995, and study investigators continue data analysis and reporting. Overlap in ages at examination among three cohorts (aged 8-12, 11-15, and 14-18 years at baseline) and use of multilevel modeling methods permit analysis of some 5500 observations on each principal variable for the synthetic cohort from ages 8 to 18 years. The mixed-longitudinal design provides trajectories of change with age, for total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides; systolic, and fourth-phase and fifth-phase diastolic blood pressure, and left ventricular mass. These trajectories are then related to concurrent measures of multiple indices of body composition and sexual maturation and adjusted for energy intake and physical activity. The data provide valuable insights into risk factor development and suggest a fresh approach to understanding influences on blood lipids, blood pressure, and left ventricular mass during the period of childhood and adolescence, a period of dynamic change in these risk factors.

Indexed as

Blood PressureAdolescentAge FactorsCardiovascular DiseasesChildData CollectionFemaleFollow-Up StudiesHeart VentriclesHumansLipidsLongitudinal StudiesMaleRacial GroupsResearch DesignRisk FactorsLipids

Identifiers

PMID19524162
PMCPMC4465373

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.